EP1034186 - SYNTHETIC PEPTIDES CONTAINING CITRULLINE RECOGNIZED BY RHEUMATOID ARTHRITIS SERA AS TOOLS FOR DIAGNOSIS AND TREATMENT [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.10.2003 Database last updated on 22.02.2019 | Most recent event Tooltip | 17.10.2003 | Application deemed to be withdrawn | published on 03.12.2003 [2003/49] | Applicant(s) | For all designated states Innogenetics N.V. Industriepark Zwijnaarde 7, Box 4 9052 Ghent / BE | [N/P] |
Former [2000/37] | For all designated states INNOGENETICS N.V. Industriepark Zwijnaarde 7, Box 4 9052 Gent / BE | Inventor(s) | 01 /
MEHEUS, Lydie Gontrodeheirweg 120 B-9820 Merelbeke / BE | 02 /
UNION, Ann Savooien 15 B-9880 Aalter / BE | 03 /
RAYMACKERS, Joseph Zuiderbiesten 10 B-9810 Eke / BE | [2000/37] | Application number, filing date | 98965715.0 | 30.11.1998 | [2000/37] | WO1998EP07714 | Priority number, date | EP19970870195 | 28.11.1997 Original published format: EP 97870195 | EP19980870078 | 09.04.1998 Original published format: EP 98870078 | [2000/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO9928344 | Date: | 10.06.1999 | Language: | EN | [1999/23] | Type: | A2 Application without search report | No.: | EP1034186 | Date: | 13.09.2000 | Language: | EN | The application has been published by WIPO in one of the EPO official languages on 10.06.1999 | [2000/37] | Search report(s) | International search report - published on: | EP | 12.08.1999 | Classification | International: | C07K14/47, C07K1/107, C07K16/18, A61K38/17, G01N33/564 | [2000/37] | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/37] | Extension states | AL | 13.06.2000 | LT | 13.06.2000 | LV | 13.06.2000 | MK | 13.06.2000 | RO | 13.06.2000 | SI | 13.06.2000 | Title | German: | CITRULLIN-ENTHALTENDE SYNTHETISCHE PEPTIDE, REAKTIV MIT SEREN VON PATIENTEN MIT RHEUMATISCHE ARTHRITIS, ZUR DIAGNOSE UND BEHANDLUNG | [2000/37] | English: | SYNTHETIC PEPTIDES CONTAINING CITRULLINE RECOGNIZED BY RHEUMATOID ARTHRITIS SERA AS TOOLS FOR DIAGNOSIS AND TREATMENT | [2000/37] | French: | PEPTIDES SYNTHETIQUES CONTENANT UNE CITRULLINE RECONNUE PAR LES SERUMS DE MALADES ATTEINTS DE POLYARTHRITE RHUMATOIDE COMME DES OUTILS DE DIAGNOSTIC ET DE TRAITEMENT | [2000/37] | Entry into regional phase | 13.06.2000 | National basic fee paid | 13.06.2000 | Designation fee(s) paid | 13.06.2000 | Examination fee paid | Examination procedure | 22.06.1999 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 13.06.2000 | Examination requested [2000/37] | 01.06.2003 | Application deemed to be withdrawn, date of legal effect [2003/49] | 04.07.2003 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2003/49] | Fees paid | Renewal fee | 28.11.2000 | Renewal fee patent year 03 | 03.11.2001 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.11.2002 | 05   M06   Not yet paid | Cited in | International search | [PX]WO9822503 (STICHTING SCHEIKUNDIG ONDERZOE [NL], et al) [PX] 1-14,16-26 * the whole document *; | [XP]WO9808946 (BIOMERIEUX SA [FR], et al) [XP] 1-14,16-26 * the whole document * * page 4, line 20 - line 30 * * page 6 - page 7; claim - *; | [X]WO9219649 (CLONATEC SA [FR]) [X] 1,3-11,13,14,16-26 * page 4, line 22 - line 33 * * abstract *; | [A]US5660994 (BRUDER-HEID GERDA [DE], et al) [A] * table 1 * | [PX] - G.A. SCHELLEKENS ET AL., "CITRULLINE IS AN ESSENTIAL CONSTITUENT OF ANTIGENIC DETERMINANTS RECOGNISED BY RHEUMATOID ARTHRITIS-SPECIFIC AUTOANTIBODIES", J. CLIN. INVEST., (199801), vol. 101, no. 1, pages 273 - 281, XP002105185 [PX] 1-14,16-26 * abstract * | [X] - SCHELLEKENS G A ET AL, "THE MODIFIED ARGININE RESIDUE CITRULLINE IS THE MAJOR CONSTITUENT OF EPITOPES RECOGNIZED BY AUTOANTIBODIES IN SERA FROM RHEUMATOID ARTHRITIS PATIENTS", ARTHRITIS AND RHEUMATISM, (19971108), vol. 40, no. 9, SUPPL. 08, page S276, XP002067877 [X] 1,3-11,13,14,16-26 * abstract * | [X] - T.SENSHU ET AL, "Preferential deimination of keratin K1 and Filaggrin during the terminal differentiation of human epidermis", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS., ORLANDO, FL US, (1996), vol. 225, pages 712 - 719, XP002105186 [X] 1,2,6 * abstract * * page 717, paragraph L * DOI: http://dx.doi.org/10.1006/bbrc.1996.1240 | [X] - E. TARCSA ET AL., "Protein unfolding by peptidylarginine deiminase", J. BIOLOGICAL CHEMISTRY, (199611), vol. 271, no. 48, pages 30709 - 30716, XP002105187 [X] 1,2,6,9-12 * abstract * * table I * DOI: http://dx.doi.org/10.1074/jbc.271.48.30709 | [A] - SIMON M ET AL, "THE CYTOKERATIN FILAMENT-AGGREGATING PROTEIN FILAGGRIN IS THE TARGET OF THE SO-CALLED " ANTIKERATIN ANTIBODIES," AUTOANTIBODIES SPECIFIC FOR RHEUMATOID ARTHRITIS", JOURNAL OF CLINICAL INVESTIGATION, (19930901), vol. 92, no. 3, pages 1387 - 1393, XP002038026 DOI: http://dx.doi.org/10.1172/JCI116713 |